Neurology 1303 - Neurology Alert - Mar 01, 2009

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Dara G. Jamieson, MD,
Associate Professor of Clinical Neurology,
Weill Cornell Medical College, New York, NY

Charles P. Pollak, MD,
Professor of Clinical Neurology, Weill Cornell Medical College

Norman R. Relkin, MD, PhD,
Director, Memory Disorders Program,
Associate Professor of Clinical Neurology, 
Weill Cornell Medical College

Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience,
Comprehensive Epilepsy Center,
Weill Medical College

Dana Leifer, MD,
Associate Professor of Clinical Neurology,
Weill Cornell Medical College

Michael Rubin, MD FRCP(C)
Professor of Clinical Neurology
Weill Medical College of Cornell University
NewYork Presbyterian Hospital

Subjects:

  • The Calcitonin Gene-Related Peptide Receptor: A New Source of Acute Migraine Relief
  • Stroke Is Associated with Central Periodic (Cheyne-Stokes) Breathing
  • Congenital Myopathy 2009
  • Alzheimer Immunotherapy Can Alter Vascular Amyloid
  • CNS Infections: An Indication for Continuous EEG Monitoring?
  • Decreased Size of Acute Ischemic Stroke: An Additional Benefit from Chronic Warfarin Therapy?

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert’s physician editor, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study.
Assistant editors Charles P. Pollak, MD, Padmaja Kandula, MD, Dana Leifer, MD, and peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Dara G. Jamieson, MD reports she is a retained consultant for Boehringer Ingelheim, Merck, and Ortho-McNeil, and is on the speaker's bureau for Boehringer Ingelheim and Merck. Assistant editor Michael Rubin, MD, FRCP(C) reports that he receives grant/research support from Pfizer and is on the speaker's bureau of Athena Diagnostics. Assistant editor Norman R. Relkin, MD, PhD reports that he receives grant/research support from Baxter Bioscience, and is a consultant to Eisai, Pfizer, Myriad, and Smart Genetics.

Copyright 2009 AHC Media. All rights reserved.